about
Bitolterol mesylate: a beta-adrenergic agent. Chemistry, pharmacokinetics, pharmacodynamics, adverse effects and clinical efficacy in asthmaRisk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonistsA comparison of the ventilatory, cardiovascular and metabolic effects of salbutamol, aminophylline and vasoactive intestinal peptide in normal subjects.Cardiovascular and biochemical responses to nebulised salbutamol in normal subjectsNebulisers for asthma.Acute myocardial infarction associated with albuterol.Cardiac effects of salbutamol given by air driven nebuliser at homeUse of anti-asthma drugs in New Zealand.Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study.Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment.Asthma in older people.Dosage and delivery of nebulised beta agonists in hospital.Unsuspected coronary artery disease revealed by administration of nebulised salbutamol.Treatment for acute asthma in the ambulance.Home nebulisers for airflow limitation.Risk of myocardial ischaemia and beta-adrenoceptor agonists.Antiasthma drugs: key issues in clinical trial methodology.The puzzle of continued use of nebulized therapy by those with asthma.
P2860
Q28306420-19370C8A-63C7-412C-931B-2D4B28929CB9Q28369181-5BA17116-9F9B-4CA0-B0F1-6F7A073551E8Q34447835-0A88CA71-0D1E-43C0-8E85-4298A2FB72F9Q34621827-83CDCF46-1E63-41D0-A5AF-02FDDF625896Q35577134-3EE35D63-8788-41BD-9029-84D73898D5CEQ35923138-846B7CCA-91CD-4395-A2FC-A685F49D4C82Q36154271-C0076A7F-718D-4E22-8D5A-8BB39BCA7C3DQ36172000-D8958E50-DC85-4F38-90B6-6D8B975BEBA0Q36196966-DAF85D99-A482-4BFC-A1D9-FC4BE2B5DD4CQ37184413-DF94E217-A7F8-4497-A8EF-A823589B078FQ37619664-6784B876-1070-4AFB-A67D-A99985BBCA38Q40824449-B4078B28-3C52-40A4-BDB2-242E54F9E48DQ41120436-ED9020B8-F9A9-4711-9A17-53AAF20CD173Q42578582-3BF8A8E5-F1A5-4DBF-ACD3-520157A39D8BQ43208177-895F401D-2BFD-42B7-9876-1235B2DA533DQ43252642-DBD1D501-88D4-4135-B74E-205E4F56A3F6Q44260780-7E73A466-52D4-4349-A937-7370F5794F27Q44426196-D04D1664-B9F9-40AF-8189-45BD6D2A8BDAQ55052551-5B68D11F-48DB-4BF1-B442-0182217D4240
P2860
description
1982 nî lūn-bûn
@nan
1982 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Nebulised salbutamol and angina
@ast
Nebulised salbutamol and angina
@en
Nebulised salbutamol and angina
@nl
type
label
Nebulised salbutamol and angina
@ast
Nebulised salbutamol and angina
@en
Nebulised salbutamol and angina
@nl
prefLabel
Nebulised salbutamol and angina
@ast
Nebulised salbutamol and angina
@en
Nebulised salbutamol and angina
@nl
P2093
P2860
P356
P1433
P1476
Nebulised salbutamol and angina
@en
P2093
P2860
P356
10.1136/BMJ.285.6344.796
P407
P577
1982-09-18T00:00:00Z